China is caught between its strategic priority of strong economic growth, which will be crucial if China is to achieve its ambition of global political dominance, and escalating COVID-19 cases across the country.
But while most nations have balanced vaccination with reopening, the Chinese Communist Party maintains that vaccinations and a zero-infection rate must go together. In turn, authorities are moving to reimpose strict lockdowns on movement and gatherings. This is further repressing retail spending growth and threatens China’s economic targets for the end of 2021. While Chinese President Xi Jinping might be tempted to loosen the zero-infection focus, it’s unclear whether his CoronaVac and Sinopharm vaccines offer sufficient protection from the delta variant. Nature reported that recent studies appear to show these vaccines aren’t working all that well, with antibody levels plummeting after just a few months. This would seem to risk fueling China’s susceptibility to rolling infection waves.